Hikma Pharmaceuticals PLC (Hikma) announces that it has signed an exclusive licensing and distribution agreement with Orion Corporation of Finland (Orion), for its new Easyhaler® combination product.
Boehringer Ingelheim today announced a collaboration with Weill Cornell Medicine to identify new treatment approaches for chronic obstructive pulmonary disease (COPD)...
The National Institute for Health and Care Excellence has rejected AstraZeneca's Daxas for use by the NHS to treat certain patients with chronic obstructive pulmonary disease (COPD).